Ezra Cohen to Benzimidazoles
This is a "connection" page, showing publications Ezra Cohen has written about Benzimidazoles.
Connection Strength
0.426
-
Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements. Clin Cancer Res. 2012 Apr 01; 18(7):2056-65.
Score: 0.345
-
Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244. J Am Acad Dermatol. 2011 Feb; 64(2):e17-9.
Score: 0.081